SCHEMBL4876813

SCHEMBL4876813

CCC1C(CC)[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@H]1CC(C(=O)O)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.52
LMNA P02545 7/20 0.52
MAPT P10636 6/20 0.52
TSHR P16473 5/20 0.52
SHBG P04278 5/20 0.52
HSD17B10 Q99714 4/20 0.52
SERPINA6 P08185 4/20 0.52
MAPK1 P28482 4/20 0.52
NR3C1 P04150 4/20 0.52
PGR P06401 4/20 0.52
AR P10275 4/20 0.52
GPBAR1 Q8TDU6 3/20 0.52
SIGMAR1 Q99720 3/20 0.52
CYP19A1 P11511 2/20 0.52
SNCA P37840 2/20 0.52
CACNA1C Q13936 2/20 0.52
CYP51A1 Q16850 2/20 0.52
OR51E2 Q9H255 1/20 0.52
SMN1; SMN2 Q16637 5/20 0.52
ALDH1A1 P00352 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4907204 0.89 PSEN1 (0.48) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL4885697 0.86 CYP3A4 (0.52) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL3275157 0.83 CYP3A4 (0.55) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL3747284 0.78 CYP17A1 (0.54) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL4876809 0.76 CYP3A4 (0.55) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL4895190 0.74 SHBG (0.77) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL6393057 0.74 HSD17B10 (0.55) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL4895186 0.74 SHBG (0.77) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL18799945 0.74 SHBG (0.77) CYP3A4LMNAMAPTTSHRSHBG
SCHEMBL4889469 0.74 SHBG (0.65) CYP3A4LMNAMAPTTSHRSHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080194812-A1 Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene- 17Alpha-Pregn-4-Ene-3-One-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2008-08-14 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080194812-A1 Process for the Preparation of 17-Hydroxy-6Beta, 7Beta; 15Beta, 16Beta-Bismethylene- 17Alpha-Pregn-4-Ene-3-One-21-Carboxylic Acid Y-Lactone and Key Intermediates for this Process CYP17A1, HSD17B7, HSD17B11 CYP3A4 55/4885LMNA 1403/4885MAPT 4288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.